These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15519285)

  • 41. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002.
    Arnett DK; Jacobs DR; Luepker RV; Blackburn H; Armstrong C; Claas SA
    Circulation; 2005 Dec; 112(25):3884-91. PubMed ID: 16344385
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment with statins in general medicine: dosage and effectiveness. Results of the observational study STATIMED].
    Amouyel P; Lamarque H; Gayet JL
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1206-11. PubMed ID: 16435599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H; Mendelsohn AA; Goodman SG; Jaffer S; Chen RY; Tjia S; Theriault L; Langer A; Leiter LA;
    Am J Cardiol; 2009 Sep; 104(6):798-804. PubMed ID: 19733714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
    Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation).
    Assmann G; Benecke H; Neiss A; Cullen P; Schulte H; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):776-83. PubMed ID: 17001218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential impact on cardiovascular public health of over-the-counter statin availability.
    Brass EP; Allen SE; Melin JM
    Am J Cardiol; 2006 Mar; 97(6):851-6. PubMed ID: 16516588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Is there a relationship between cholesterol reduction, low levels of cholesterol and mortality?].
    LaRosa JC
    Rev Esp Cardiol; 1995; 48 Suppl 2():14-7. PubMed ID: 7569270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. European Consensus on Primary Prevention of Coronary Heart Disease.
    Assmann G
    Can J Cardiol; 1988 Jul; 4 Suppl A():21A-23A. PubMed ID: 3052738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reclassification of simvastatin to over-the-counter status in the United Kingdom: a primary prevention strategy.
    Nash DB; Nash SA
    Am J Cardiol; 2004 Nov; 94(9A):35F-39F. PubMed ID: 15519290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New guidelines from the National Cholesterol Education Program: what is the impact on risk assessment?
    Lowden JA
    J Insur Med; 2002; 34(1):26-30. PubMed ID: 15303591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The combined use of cholesterol-lowering drugs and cholesterol-lowering bread spreads: health behavior data from Finland.
    de Jong N; Simojoki M; Laatikainen T; Tapanainen H; Valsta L; Lahti-Koski M; Uutela A; Vartiainen E
    Prev Med; 2004 Nov; 39(5):849-55. PubMed ID: 15475015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in total cholesterol levels in Western societies are not related to statin, but rather dietary factors: the example of the Icelandic population.
    Thorsson B; Steingrimsdottir L; Halldorsdottir S; Andersen K; Sigurdsson G; Aspelund T; Gudnason V
    Eur Heart J; 2013 Jun; 34(24):1778-82. PubMed ID: 23209261
    [No Abstract]   [Full Text] [Related]  

  • 55. [Cardiovascular risk patient--how much prevention is necessary and rational?].
    Seiler C
    Praxis (Bern 1994); 1998 Jan; 87(5):135-40, 142, 144. PubMed ID: 9522631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Population benefits of cholesterol reduction: epidemiology, economics, and ethics.
    Pearson TA
    Am J Cardiol; 2000 Jun; 85(12A):20E-3E. PubMed ID: 10858490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction of cholesterol in Kentucky--a state at high risk.
    Whayne TF; Zielke JC
    J Ky Med Assoc; 2000 Jun; 98(6):248-53. PubMed ID: 10870339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lowering blood cholesterol to reduce coronary heart disease risk.
    Bradford RH; Rifkind BM
    Clin Lab Med; 1989 Mar; 9(1):1-6. PubMed ID: 2647369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Understanding the implications of over the counter statin sales.
    Nuttall M
    Nurs Times; 2004 May 25-31; 100(21):28-9. PubMed ID: 15192918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study.
    Manuel DG; Kwong K; Tanuseputro P; Lim J; Mustard CA; Anderson GM; Ardal S; Alter DA; Laupacis A
    BMJ; 2006 Jun; 332(7555):1419. PubMed ID: 16737980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.